EMA — authorised 7 March 2020
- Marketing authorisation holder: Gilead Sciences Ireland UC
- Status: approved
EMA authorised Veklury on 7 March 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 7 March 2020.
Gilead Sciences Ireland UC holds the EU marketing authorisation.